1. Home
  2. MHH vs ACET Comparison

MHH vs ACET Comparison

Compare MHH & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mastech Digital Inc

MHH

Mastech Digital Inc

N/A

Current Price

$6.26

Market Cap

81.7M

ML Signal

N/A

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.33

Market Cap

69.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHH
ACET
Founded
1986
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.7M
69.6M
IPO Year
2008
2017

Fundamental Metrics

Financial Performance
Metric
MHH
ACET
Price
$6.26
$7.33
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$65.33
AVG Volume (30 Days)
15.5K
130.1K
Earning Date
05-22-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
145.90
N/A
EPS
N/A
N/A
Revenue
$198,943,000.00
N/A
Revenue This Year
$2.93
N/A
Revenue Next Year
$8.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.51
$0.45
52 Week High
$10.91
$9.05

Technical Indicators

Market Signals
Indicator
MHH
ACET
Relative Strength Index (RSI) 45.43 52.71
Support Level $5.51 $6.54
Resistance Level $7.75 $8.46
Average True Range (ATR) 0.37 0.48
MACD 0.04 -0.04
Stochastic Oscillator 65.09 49.66

Price Performance

Historical Comparison
MHH
ACET

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: